This is the authors' abstract. We don't add key points for this paper.
Introduction: Testicular sarcomas (TS) are rare, accounting for less than 1% of adult testicular tumors, with a favorable prognosis unless they are metastatic. They typically present as painless scrotal swelling and are treated with orchiectomy and adjuvant therapies. This paper aims to present a case report on the diagnosis and management of a 54-year-old man with testicular sarcoma. Case presentation: A 54-year-old man presented with a painful right scrotal mass that had progressively enlarged over the past year. A biopsy revealed a testicular tumor initially suspected to be adenocarcinoma, but subsequent immunohistochemistry confirmed testicular sarcoma. A multislice CT scan showed a large, infiltrative mass involving adjacent pelvic structures. The patient began chemotherapy with a doxorubicin-ifosfamide-mesna regimen, but he died after the first cycle. Clinical discussion: Staging of T4N0M1 indicates a locally advanced primary tumor with distant pulmonary metastases in the absence of regional lymph node involvement. The patient’s rapid death after one chemotherapy cycle likely reflects a combination of aggressive tumor biology, pre-existing systemic compromise (pneumonia, pleural effusion), and chemotherapy-related toxicity. The management intent was palliative given the metastatic presentation. Conclusion: Due to their rarity, TS are often initially misdiagnosed, highlighting the need for comprehensive clinical and pathological evaluations that include imaging and advanced immunohistochemical analysis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Prapiska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: